Full Text (PDF) CME: Take the course for this article: AJP CME Course for October 2008: Olanzapine in the Treatment of Low Body We... Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Bissada, H. Articles by Bradwejn, J. Search for Related Content PubMed Citation Articles by Bissada, H. Articles by Bradwejn, J. Related Articles

Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial

Objective: Anorexia nervosa is associated with high mortality, morbidity, and treatment costs. Olanzapine, an atypical antipsychotic, is known to result in weight gain in other patient populations. The objective of this trial was to assess the efficacy of olanzapine in promoting weight gain and in reducing obsessive symptoms among adult women with anorexia nervosa. Method: The study was a double-blind, placebo-controlled, 10-week flexible dose trial in which patients with anorexia nervosa (N=34) were randomly assigned to either olanzapine plus day hospital treatment or placebo plus day hospital treatment. Results: Compared with placebo, olanzapine resulted in a greater rate of increase in weight, earlier achievement of target body mass index, and a greater rate of decrease in obsessive symptoms. No differences in adverse effects were observed between the two treatment conditions. Conclusions: These preliminary results suggest that olanzapine may be safely used in achieving more rapid weight gain and improvement in obsessive symptoms among women with anorexia nervosa. Replication, in the form of a large multicenter trial, is recommended.

Related Articles:

The Perplexities of Conducting Randomized, Double-Blind, Placebo-Controlled Treatment Trials in Anorexia Nervosa Patients

Katherine A. Halmi
Am J Psychiatry 2008 165: 1227-1228. [Full Text] [PDF]

This article has been cited by other articles:

				V. Duvvuri and W. H. Kaye Anorexia Nervosa Focus, October 1, 2009; 7(4): 455 - 462. [Abstract] [Full Text] [PDF]

				E. Attia and B. T. Walsh Behavioral Management for Anorexia Nervosa N. Engl. J. Med., January 29, 2009; 360(5): 500 - 506. [Full Text] [PDF]

				K. A. Halmi The Perplexities of Conducting Randomized, Double-Blind, Placebo-Controlled Treatment Trials in Anorexia Nervosa Patients Am J Psychiatry, October 1, 2008; 165(10): 1227 - 1228. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us